Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for early callus formation in proximal humeral fractures
2009-017320-29Phase 4Completed
- Sponsor
- Department of Orthopaedics
- Start
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of teriparatide in proximal humerus fracture (PHF) (2 arms), sponsored by Department of Orthopaedics. Primary endpoints: Early callus formation at 7 weeks and Early callus formation at 3 months. Started Nov 2009; status: completed.
02
Drugs
teriparatide
03
Conditions
proximal humerus fracture (PHF)
Beyond the preview
Go deeper on 2009-017320-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017320-29.